Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017754684> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2017754684 endingPage "14" @default.
- W2017754684 startingPage "6" @default.
- W2017754684 abstract "BACKGROUND: Both standard and immune‐enhancing oral formulas are widely used to forestall HIV wasting and to promote immune function. However, there is little scientific evidence to support the differential effects of these formulas in asymptomatic HIV disease. The aim of this study was to compare the effects of an immune‐enhancing oral formula and a standard oral formula on nutrition and immune measures in asymptomatic HIV‐infected persons. A secondary aim was to evaluate the feasibility of maintaining a diverse sample of outpatients on a long‐term oral formula protocol. METHODS: In this multicenter controlled nonblinded study, 90 asymptomatic HIV‐infected persons with CD4 cell counts between 275 and 550 cells/mm3 were randomized to a control group; a standard oral formula group (Ensure Plus); or an immune‐enhancing oral formula group (Advera). All groups received basic nutrition counseling. Participants were evaluated on nutrition, immune, and feasibility measures at 3‐month intervals during the 12‐month study period. Differences in nutrition and immune measures among the 3 groups were analyzed using the Kruskal‐Wallis and Wilcoxon tests. Wilcoxon tests and correlation coefficients were used to analyze feasibility data. RESULTS: Sixty‐six outpatients completed the 12‐month study protocol. Among the 3 groups, there were no significant differences with respect to body weight, bioelectrical impedance analysis (BIA)‐derived body cell and fat mass, daily caloric intake, and serum albumin at any of the study visits. Moreover, absolute CD4+ T lymphocytes and percentages did not significantly differ at any time point among the 3 groups. Acceptability and tolerance of the formulas were high for both the standard and immune‐enhancing oral formula groups. CONCLUSIONS: Within the context and limitations of this study, standard and immune‐enhancing oral formulas consumed daily for 1 year had no differential effects on nutrition or immune parameters in asymptomatic HIV‐infected persons." @default.
- W2017754684 created "2016-06-24" @default.
- W2017754684 creator A5009568141 @default.
- W2017754684 creator A5019282915 @default.
- W2017754684 creator A5020407745 @default.
- W2017754684 creator A5030438967 @default.
- W2017754684 creator A5055873183 @default.
- W2017754684 creator A5059892746 @default.
- W2017754684 creator A5083470674 @default.
- W2017754684 date "2002-01-01" @default.
- W2017754684 modified "2023-09-30" @default.
- W2017754684 title "Comparison of standard and immune-enhancing oral formulas in asymptomatic HIV-infected persons: a multicenter randomized controlled clinical trial" @default.
- W2017754684 doi "https://doi.org/10.1177/014860710202600106" @default.
- W2017754684 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11833753" @default.
- W2017754684 hasPublicationYear "2002" @default.
- W2017754684 type Work @default.
- W2017754684 sameAs 2017754684 @default.
- W2017754684 citedByCount "34" @default.
- W2017754684 countsByYear W20177546842013 @default.
- W2017754684 countsByYear W20177546842014 @default.
- W2017754684 countsByYear W20177546842016 @default.
- W2017754684 countsByYear W20177546842017 @default.
- W2017754684 countsByYear W20177546842018 @default.
- W2017754684 countsByYear W20177546842019 @default.
- W2017754684 crossrefType "journal-article" @default.
- W2017754684 hasAuthorship W2017754684A5009568141 @default.
- W2017754684 hasAuthorship W2017754684A5019282915 @default.
- W2017754684 hasAuthorship W2017754684A5020407745 @default.
- W2017754684 hasAuthorship W2017754684A5030438967 @default.
- W2017754684 hasAuthorship W2017754684A5055873183 @default.
- W2017754684 hasAuthorship W2017754684A5059892746 @default.
- W2017754684 hasAuthorship W2017754684A5083470674 @default.
- W2017754684 hasConcept C126322002 @default.
- W2017754684 hasConcept C168563851 @default.
- W2017754684 hasConcept C203014093 @default.
- W2017754684 hasConcept C2777910003 @default.
- W2017754684 hasConcept C2780221984 @default.
- W2017754684 hasConcept C33872192 @default.
- W2017754684 hasConcept C535046627 @default.
- W2017754684 hasConcept C71924100 @default.
- W2017754684 hasConcept C8891405 @default.
- W2017754684 hasConceptScore W2017754684C126322002 @default.
- W2017754684 hasConceptScore W2017754684C168563851 @default.
- W2017754684 hasConceptScore W2017754684C203014093 @default.
- W2017754684 hasConceptScore W2017754684C2777910003 @default.
- W2017754684 hasConceptScore W2017754684C2780221984 @default.
- W2017754684 hasConceptScore W2017754684C33872192 @default.
- W2017754684 hasConceptScore W2017754684C535046627 @default.
- W2017754684 hasConceptScore W2017754684C71924100 @default.
- W2017754684 hasConceptScore W2017754684C8891405 @default.
- W2017754684 hasIssue "1" @default.
- W2017754684 hasLocation W20177546841 @default.
- W2017754684 hasLocation W20177546842 @default.
- W2017754684 hasOpenAccess W2017754684 @default.
- W2017754684 hasPrimaryLocation W20177546841 @default.
- W2017754684 hasRelatedWork W129423339 @default.
- W2017754684 hasRelatedWork W1987215768 @default.
- W2017754684 hasRelatedWork W1991129960 @default.
- W2017754684 hasRelatedWork W1995188757 @default.
- W2017754684 hasRelatedWork W2007817983 @default.
- W2017754684 hasRelatedWork W2016679923 @default.
- W2017754684 hasRelatedWork W2116001782 @default.
- W2017754684 hasRelatedWork W2943195325 @default.
- W2017754684 hasRelatedWork W4229900919 @default.
- W2017754684 hasRelatedWork W17604275 @default.
- W2017754684 hasVolume "26" @default.
- W2017754684 isParatext "false" @default.
- W2017754684 isRetracted "false" @default.
- W2017754684 magId "2017754684" @default.
- W2017754684 workType "article" @default.